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Methods for functionalization of the oxindole nucleus are of 
significant value in medicinal chemistry and natural product 
synthesis.1 Due to their unprecedented structural diversity, 
biological activity and structural challenge, oxindoles continue to 
attract the interest of chemists and biologists alike. For example, 
the convolutamydines,2 and the 3-hydroxywelwitindolinones are 
part of a growing list of biologically active 3-hydroxyoxindoles 
(Figure 1).3 3-Hydroxyoxindoles with a quaternary benzylic 
centre are a useful class of compounds also found in several drug 
candidates, including the potent, orally active growth hormone  
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Figure 1. Exemplar biologically active C-3 hydroxy oxindoles 
secretagogue SM-130686,4 a drug that currently is under 
investigation for the treatment of growth hormone deficiency and 
other medical conditions (Figure 1).5 
There are a number of reports on the enantioselective 
formation of quaternary carbon centers at the 3-position of 
oxindoles.6 For example, Hartwig first reported the palladium-
catalysed synthesis of oxindoles by amide α-arylation with ees of 
up to 67%;7 This was later improved upon by Kündig using 
modified N-heterocyclic carbenes8 and Marsden has reported 
several methods for the synthesis of 3-hydroxy- and 3-amino-
oxindoles.9 
Copper-mediated processes have also recently been employed 
to prepare quaternary C-3 oxindoles by both the Kündig10 and 
Taylor groups.11 Also of note are the recent reports by Franz,12 
who has reported the asymmetric direct addition of nucleophiles 
to isatins using chiral Lewis acids, and Shibata and Toru who 
have reported the asymmetric C-3 hydroxylation of oxindoles 
also using chiral Lewis acids, with an oxaziridine as the 
stoicheiometric oxidant.13 Thus owing to the significance of the 
oxindole structural motif, the development of catalytic methods 
for the synthesis of oxindoles bearing a C-3 hydroxy quaternary 
centre is highly desirable.  
Gassman and Halweg reported the air oxidation of oxindoles 
to isatins (Scheme 1) through treatment of 3-methylthiooxindoles 
with a strong stoicheiometric base and air; strict anhydrous 
conditions were required in order to prevent degradation of the 
isatin to the corresponding anthranilic acid.14 We also noted the 
recent report from Curran and co-workers,15 where the attempted 
removal of the trimethylsilyl (TMS) group from 1 resulted in 3-
hydroxy-1,3-dihydroindol-2-one 2 being the sole product of the 
reaction (Scheme 2). Careful investigation of Curran’s reaction 
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Scheme 1. Gassman and Halweg’s route to isatins 
 
conditions revealed the use of 1.1 equivalents of 
tetrabutylammonium fluoride (TBAF); as 1.0 equivalent was 
required to fully desilylate the aryl ring we postulated that in 
order for 3-hydroxy-1,3-dihydroindol-2-one to be the sole 
product of the reaction, base-catalysed aerial oxidation must 
occur. We believed that this interesting unwanted side reaction 
could be a practical, mild solution to the synthesis of 3-
hydroxyoxindoles using a readily available organocatalyst 
(TBAF) and a benign oxidant (air). This is even more important 
when one considers that from both an economic and 
environmental viewpoint there is currently an urgent need for 
more atom efficient systems that employ environmentally benign 
oxidants such as H2O2 or more preferably O2.16 
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Scheme 2. Curran’s attempted removal of the trimethylsilyl 
group from 1. 
 
We started our investigation by looking at the aerial oxidation 
of 1,3-dimethyl-1,3-dihydroindol-2-one 3a using varying 
equivalents of TBAF in tetrahydrofuran as the solvent.17 We were 
delighted to find that the reaction was extremely rapid at room 
temperature and excellent yields of the hydroxylated oxindole 4a 
were observed with catalyst loadings as low as 10 mol%. Below 
this level we observed poor conversion into the desired product 
perhaps due to the breakdown of catalyst–counterion pairs at low 
catalyst concentration.18 
Using our optimized conditions (THF, 20 mol% TBAF)19 we 
screened a range of 3-alkyloxindoles, and again we were 
delighted to find that excellent yields of the corresponding 3-
hydroxyoxindoles 4c-4j were achieved (Table 1). We were also 
interested to see if our system was able to oxidise 3-aryl 
oxindoles as this motif is present in a variety of natural products 
and biologically important molecules (see Figure 1 for example); 
again we observed excellent conversion into the hydroxylated 
products 4k-4p. These results are important when considering the 
recent report in which Itoh and co-workers described the 
asymmetric aerial phase-transfer oxidation of oxindoles (using 
aq. KOH as a stoicheiometric base): they noted that benzyl 
protected oxindoles gave poor yields of C-3 hydroxylated 
products, also that the Boc protecting group is not tolerated under 
their reaction conditions; further they did not report the oxidation 
of oxindoles with aromatic groups at C-3.20 Jiang and Tan have 
also reported the molecular oxygen oxidation of oxindoles 
employing a stoichieometric base and a chiral pentadinium salt, 
but the substrate screen was narrow with the only group at 
nitrogen studied being p-methoxybenzyl.21 Our procedure 
appears quite general with the protecting group on nitrogen 
having little influence on the reaction, however, a group at 
nitrogen is essential for the reaction to occur (see 4b, Table 1 for 
example, this is presumably due to deprotonation of the nitrogen 
in preference to enolate formation). 
Table 1. Application to a range of substratesa,b 
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a General conditions: TBAF (1 M in THF, 0.2 equiv.), THF (2 
mL), open vessel, r.t., 24 h19; b Percentage yields shown refer to 
the isolated yield after chromatography. 
Intrigued by these findings we also carried out a competition 
experiment through the addition of an electrophile to the reaction. 
For example, when 3g is treated with TBAF (0.2 equiv.) in THF 
the oxidized oxindole 4g is the sole product (Table 1), however, 
if 1,3-Dichloro-5,5-dimethylhydantoin (DCDMH) is added prior 
to the addition of TBAF then chlorination at C-3 is observed (to 
afford 5 along with recovered starting material 3g, Scheme 3) 
with no C-3 hydroxylated product 4g being detectable by 1H 
NMR spectroscopy or TLC analysis. Suggesting that quenching 
of the enolate with an electrophile other than O2 is more facile 
and that the reagent used inhibits formation of the enolate after 1 
turnover of the system, thus only 15% of chlorinated product is 
observed from the use of 20 mol% TBAF. When 1 equivalent of 
TBAF is employed complete conversion into 5 is observed. 
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Scheme 3. Competition experiment by addition of DCDMH 
to the reaction. 
 
A proposed catalytic cycle is outlined in Scheme 4. Treatment 
of the oxindole 3 with TBAF affords the tetrabutylammonium 
enolate 6 plus HF, following Path A addition of O2 affords the 
peroxide anion 7 and recombination with a molecule of HF 
affords the peroxide 8 plus TBAF which can re-enter the catalytic 
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3 
cycle.22 In order to break down the peroxide 8 we propose that 
another molecule of the enolate 6 intercepts 8 (Path B) and 
affords two molecules of the hydroxylated product 4 plus another 
molecule of TBAF. 
Recently Garg23 and Rawal24 both independently described 
their routes to (−)-3-hydroxy-N-methylwelwitindolinone C 
isothiocyanate employing a strong base, and in the case of Garg, 
air and Rawal an oxaziridine as oxygen source for the C-3 
hydroxylation reaction (Scheme 5). Employing our TBAF 
conditions to a model substrate 9, shown in Scheme 6, which was 
prepared by analogy to that reported previously by Garg,17,25 we 
were able to establish that excellent yield of the C-3 hydroxylated 
product 10 could be achieved. 
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Scheme 4. Proposed catalytic cycle 
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Scheme 5. Garg and Rawal’s independent routes to the 3-
hydroxywelwitindoline 
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Scheme 6. Application towards the 3-hydroxywelwitindolines 
 
In conclusion, we have developed a mild catalytic process for 
the hydroxylation of oxindoles at the C-3 position using an 
environmentally benign terminal oxidant that appears to be of 
general use to a wide range of protected oxindoles. The protocol 
is also effective for hindered substrates such as the 
welwitindolinone model 9. In addition stoicheiometric TBAF is 
an effective base for halogenation at the C-3 position of 
oxindoles. 
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